Craft

Advanced
Symphogen

Symphogen

Total Funding

$387.2 M

Symphogen Summary

Company Summary

Overview
Symphogen is a biotech company focused on oncology and immuno-oncology. It is engaged in the discovery and development of antibody therapeutics. Its approach is suited for combination therapies of cancer treatment.
Type
Private
Status
Active
Founded
2000
HQ
Ballerup, DK | view all locations
Website
http://www.symphogen.com
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Mikkel Wandahl Pedersen

    Mikkel Wandahl Pedersen, SVP and Acting Chief Scientific Officer

    • Christophe Thurieau

      Christophe Thurieau, Chief Executive Officer & Director

      • Claude Bertrand

        Claude Bertrand, Chairman of the Board

        • Pascal Lemaire

          Pascal Lemaire, Director

          LocationsView all

          2 locations detected

          • Ballerup HQ

            Denmark

            Pederstrupvej 93

          • Somerville, NJ

            United States

            50 Division St #503

          Competitors and Similar Companies

          Compare competitors

          Footer menu

          Product

          Solutions

          Resources

          Company

          © Craft.co 2026
          Share price data provided by IEX